Organisation paid for research Program year 2020 Source: CMS Open Payments

Beach Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$294,542

20 payments

Through program year 2020, Beach Clinical Research is reported as receiving $294,542 in research payments, across 20 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$66,220	6
2019	Research	$228,322	14

Breakdown

Who paid Research payments · program years 2019–2020

Teva Pharmaceuticals USA, Inc. $238,580 13 payments
GlaxoSmithKline, LLC. $46,453 6 payments
Novartis Pharmaceuticals Corporation $9,510 1 payment

Studies the money was for Research payments · program years 2019–2020

A Randomized, Multiple-Dose, Blinded, Placebo-Controlled, Parallel-Design, Multiple-Center, Clinical Study to Evaluate the Therapeutic Equivalence of Fluticasone Propionate and Salmeterol Inhalation Powder, 100 mcg/50 mcg to ADVAIR DISKUS 100/50 (Fluticasone Propionate/Salmeterol) Inhalation Powder, in Subjects With Asthma $238,580 13 payments
A Phase III, Randomized, Double-Blind, Active Controlled, Parallel Gro $46,453 6 payments
A Randomized Double Blind Placebo Controlled Event Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post Myocardial Infarction Patients With Elevated Hscrp $9,510 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.